Prof Luke O’Neill, a biochemist at Trinity College Dublin, suggested the data coming from pharmaceutical giant Pfizer is very promising. Photograph: Nick Bradshaw

Epidemiologist Professor Luke O’Neill has said he is confident a vaccine for Covid-19 will be available by the end of the year. Prof O’Neill, a bioc(...)

The Pfizer vaccine is being tested on  38,000 people worldwide. Photograph: Jakub Porzycki/NurPhoto via Getty Images

Pfizer will apply for emergency US approval of the Covid-19 vaccine it is developing with Germany’s BioNTech in the third week of November, the pharma(...)

Poseida, in which Malin holds a 15% stake, plunged in August after a safety trial for one of its early-stage pipeline products, a prostate cancer drug, was  halted following a patient death. Photograph: Joe Raedle/Getty

Cash return by Dublin-listed life sciences investment firm eclipses current market value

AstraZeneca. Photograph: Lynne Cameron/PA Wire

AstraZeneca started late-stage trials for an antibody medicine against Covid-19 with a large investment from the US, after President Donald Trump cred(...)

Remdesivir has been shown to be effective on patients who require supplementary oxygen and is the only Covid-19 pharmacological treatment option licensed for use in Ireland. Photograph: Ulrich Perrey/Pool/AFP via Getty Images

Unlike an increasing number of European countries, Ireland is not experiencing shortages of the drug remdesivir, which is used to treat Covid-19 and r(...)

US president Donald Trump: is on what may be a unique cocktail of medications. Photograph: Tia Dufour/White House/AFP

President Donald Trump has received a combination of powerful drugs to battle his Covid-19 infection that may never have been prescribed together to a(...)

An image  provided by Regeneron Pharmaceuticals showing scientists working with a bioreactor at its facility in New York state. Photograph: Regeneron via AP

President Donald Trump has received a dose of an experimental antibody treatment being developed by drugmaker Regeneron, in addition to several other (...)

A laboratory technician handles vials as part of filling and packaging tests for the production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11th, 2020 at the Italian biologics manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome. Photograph: Vincenzo PINTO / AFP

The morning after the world learned that a closely watched clinical trial of a coronavirus vaccine – being developed by AstraZeneca and Oxford Univers(...)

Photograph: iStock

AstraZeneca has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a st(...)

A pedestrian wearing a protective mask passing in front of a sign outside Pfizer headquarters in New York.

The chief executive of Pfizer has warned about the reputational risks of fast-tracking a Covid-19 vaccine, as governments put pressure on pharmaceutic(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »